American Society of Hematology

Fig. 3.

$Fig. 3. Survival data in 119 patients with recurrent or refractory HD according to preparatory regimen received before autografting. CCNU/VP16/Cy (n = 19), solid line; BCNU/VP16/Cy (n = 74), dot and dash line; fTBI/VP16/Cy (n = 26), dotted line. (A) Overall survival. (B) Freedom from progression. (C) Event-free survival.$

Survival data in 119 patients with recurrent or refractory HD according to preparatory regimen received before autografting. CCNU/VP16/Cy (n = 19), solid line; BCNU/VP16/Cy (n = 74), dot and dash line; fTBI/VP16/Cy (n = 26), dotted line. (A) Overall survival. (B) Freedom from progression. (C) Event-free survival.

This Feature Is Available To Subscribers Only